|
Talmadge E. King, Jr., MD is the recepient of the Julius R. Krevans Distinguished Professorship in Internal Medicine award and Chairman of the Department of Medicine at the University of California, San Francisco (UCSF). Dr. King is a graduate of Gustavus Adolphus College and received his medical degree from Harvard Medical School, followed by a residency at Emory University Affiliated Hospitals, Atlanta, Georgia, and a pulmonary fellowship at the University of Colorado Health Sciences Center, Denver. He held a professorship in medicine at the University of Colorado Health Sciences Center, and was a senior faculty member at the National Jewish Medical and Research Center. He is a member of the Institute of Medicine of the National Academy of Sciences, Association of American Physicians, American Clinical and Climatological Association, Fleischner Society, and is a fellow of the American College of Physicians and the American College of Chest Physicians. Dr. King is an active member of a number of professional societies and is a past President of the American Thoracic Society (ATS). Dr. King has served on the Lung Biology and Pathology Study Section of the NIH; the Board of the American Board of Internal Medicine; American Board of Medical Specialties, Pulmonary and Allergy Drugs Advisory Committee Center for Drug Evaluation & Research of the FDA; NIH Advisory Board for Clinical Research (ABCR), and the Board of Extramural Advisors of the National Heart Lung and Blood Institute. He is a member of the editorial boards of American Journal of Respiratory and Critical Care Medicine, Annals of Internal Medicine, THORAX, and UpToDate™ In Pulmonary and Critical Care. He has been an editorial consultant for more than a dozen journals. For 9 years he was a member of the Board of Trustees of Gustavus Adolphus College. Dr. King has won numerous awards, among them election to the Colorado Pulmonary Hall of Fame. Dr. King has been listed on several of the "best doctors" list in America for more than a decade
(including "Best Doctors in America" and "America's Top Doctors"). His bibliography comprises
>200 publications including peer-reviewed journal articles; book chapters, critical reviews, editorials, and monographs.
He has co-authored 8 books including the acclaimed reference book "Interstitial Lung Disease", now in its 4th edition.
He recently co-edited "Medical Management of Vulnerable & Underserved Patients: Principles, Practice, Population,"
the only reference currently available that focuses on the treatment of patients living with chronic diseases in poor and minority populations.
Our overall focus has been on understanding the pathogenesis,
diagnosis and management of inflammatory and immunology
lung injury. In particular, we are improving our understanding
of the immunopathogenesis of idiopathic pulmonary fibrosis.
Another aim is to develop and evaluate methods that
can serially identify the presence and extent of disease
activity in these patients. With support from the Department
of Medicine, we have developed an Interstitial Lung
Disease Center of Excellence.
Dr. King’s bibliography comprises hundreds of publications
including peer-reviewed journal articles; book chapters,
review, editorials; books, monographs, and abstracts.
Please visit PubMed for entire list.
Some recent publications include:
Selman, M. King TE, Jr, Pardo A. Idiopathic Pulmonary
Fibrosis: Prevailing and evolving hypotheses about its
pathogenesis and implications for therapy. Ann Intern
Med 2001; 134:136-151 .[Abstract/Free Full Text]
King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV,
Waldron JA Jr., Flint A, Thurlbeck WM, Cherniack RM.
Idiopathic Pulmonary Fibrosis. Relation Between Histopathologic
Features and Mortality. Am. J. Respir. Crit. Care Med
2001; 164:1025-1032
Schwarz, MI, King TE Jr. (eds) Interstitial Lung Disease
(4th Edition). B.C. Decker, Inc., Hamilton, 2003
Crapo JD, Glassroth J, Karlinsky J. King TE, Jr. Baum's
Textbook of Pulmonary Medicine. 7th Ed., Lippincott
Williams & Wilkins, Philadelphia, 2004
Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW,
Schwartz DA, King TE Jr., for the IPF Study Group. A
placebo-controlled trial of interferon gamma-1b in patients
with idiopathic pulmonary fibrosis N Engl J Med 2004;
350:125-133 [Abstract/Free Full Text]
King TE Jr., Safrin S., Starko KM, Bradford WZ, Brown KK, Noble PW, Raghu G, Schwartz DA, Analyses of Efficacy Endpoints in a Controlled Trial of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis. Chest 2005; 127:171-177
[Abstract/Free Full Text]
King TE Jr. [ATS Centennial Review] Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases. Am J Respir Crit Care Med 2005; 172:268-279.
[Abstract/Free Full Text]
Lynch DA, Travis WD, Muller N, Galvin JR, Hansell DM, Grenier P, King TE Jr. Idiopathic interstitial pneumonias: radiologic features. Radiology. 2005;236:10-21.
[Abstract/Free Full Text]
Freemer MM, King TE Jr. Criswell LA. Association of smoking with dsDNA autoantibody production in SLE. Annals of the Rheumatic Diseases 2006;65:581-584.
[Abstract/Free Full Text]
King TE, Jr., Wheeler M, Bindman A, Fernandez A, Grumbach K, Schillinger D, Villela T. Medical Management of Vulnerable & Underserved Patients: Principles, Practice, & Populations. McGraw-Hill Com., New York, NY, pp. 408; 2007. ISBN: 0071443312 DOI: 10.1036/0071443312
[Abstract/Free Full Text]
King TE Jr, Selman M. (Guest editors) Idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3:283-393
|
